The Collaborative Cross (CC) mouse model is a next-generation mouse genetic reference population (GRP) designated for a high-resolution quantitative trait loci (QTL) mapping of complex traits during health and disease. The CC lines were generated from reciprocal crosses of eight divergent mouse founder strains composed of five classical and three wild-derived strains. Complex traits are defined to be controlled by variations within multiple genes and the gene/environment interactions. In this article, we introduce and present variety of protocols and results of studying the host response to infectious and chronic diseases, including type 2 diabetes and metabolic diseases, body composition, immune response, colorectal cancer, susceptibility to Aspergillus fumigatus, Klebsiella pneumoniae, Pseudomonas aeruginosa, sepsis, and mixed infections of Porphyromonas gingivalis and Fusobacterium nucleatum, which were conducted at our laboratory using the CC mouse population. These traits are observed at multiple levels of the body systems, including metabolism, body weight, immune profile, susceptibility or resistance to the development and progress of infectious or chronic diseases. Herein, we present full protocols and step-by-step methods, implemented in our laboratory for the phenotypic and genotypic characterization of the different CC lines, mapping the gene underlying the host response to these infections and chronic diseases. The CC mouse model is a unique and powerful GRP for dissecting the host genetic architectures underlying complex traits, including chronic and infectious diseases.
| INTRODUC TI ON
The laboratory mouse is one of the most important tools in the scientific research to understand the mammalian gene function.
The scientific community has taken advantage of this mouse because of its fundamental similarity to humans at the genetic level (>95% at the gene level), physiological and anatomical similarity, relatively low cost compared to other mammals, and nearly 100 years of genetic study. Janan Eppig of The Jackson Laboratory recently presented the results of a survey of the Mouse Genome Informatics (MGI) (http://www.infor matics.jax.org) of published model organisms used in studies of human disease. The study demonstrates the rise of the mouse as the most common experimental organism to study human disease and gene function. In genetically defined strains of mice, chromosomal regions responsible for the genetic variance of complex traits can be mapped as quantitative trait loci (QTL) in experimental populations available for precise study under defined conditions. [1] [2] [3] Once QTL is identified, genetic analysis can be extended successfully to humans. 4, 5 It has been suggested that the variation among strains of mice can be used for mapping QTL associated with susceptibility to chronic and infectious diseases. [6] [7] [8] [9] [10] Here, we propose to use advanced next-generation approach for determining the genes involved in the development of complex trait diseases and various comorbidities using the CC mouse genetic reference population (GRP). Once inbred lines of mice are crossed, the cross-progeny often exhibit transgressive variation or present novel traits that were not present in the parental strains. This indicates that the inbred strains of mice harbor a tremendous amount of natural genetic variation, above what is seen when the lines themselves are compared. This variation has been accessed in part by construction of recombinant inbred lines (RIL) derived from crosses between mouse pure lines. 11 However, the number of available RIL is too small to provide reliable statistical support to detect smaller genetic effects. With the realization that a new model population was needed to understand complex human diseases, the Collaborative Cross (CC) was designed to generate a large number of RIL. 11 The CC population is being created and developed by community efforts of the complex trait consortium (CTC, www.compl extra it.org). This unique genetic resource eventually comprises a set of approximately 100 RIL that will be created by full reciprocal eight-way mating of eight divergent strains of mice: A/J, C57BL/6J, 129S1/SvImJ, NOD/LtJ, NZO/HiLtJ, CAST/Ei, PWK/PhJ, and WSB/EiJ. Controlled randomization and minimization of selection during the breeding process recombined the natural genetic variation presented in these inbred strains ( Figure 1 ). The result is a unique collection of RIL exhibiting a large phenotypic and genetic diversity, and bringing the tremendous genetic variation potential of the mouse inbred lines to phenotypic expression. 2, 11 Full details of CC lines and their power of mapping QTL with host susceptibility to complex traits are presented in various publications. [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] The CC mouse model is the focal point in our research, having exclusive access to the CC lines produced at our laboratory at Tel-Aviv University (TAU).
The CC lines were three times genotyped, once using 620 000 single nucleotide polymorphisms (SNPs) markers of mouse diversity array, 25 once with mouse universal genotype array (MUGA), and later on, with the MegaMUGA genotype array. The updated genotype status of the population was presented recently 19 showing the diversity of the phenotypic response of the CC lines with a complex disease and their power for mapping QTL associated with this trait to a small genomic interval less than 0.5 cm, which consists of few genes. Herein, we present our various protocols and methods implemented while using the CC mouse population for dissecting the genetic architecture underlying the phenotypic variations (complex traits) observed among certain populations.
Order of protocols' presentation starts with: (a) phenotyping protocols, that is, traits at baseline/ chronic diseases/ colorectal cancer and infectious diseases, and then (b) genotyping and bioinformatics protocols, that is, genotyping methods, QTL analysis using HAPPY software, merge analysis, and founder effect.
F I G U R E 1 Funnel breeding schemes of the Collaborative Cross (CC) lines by eight founder strains. Each CC line originates from an independently breeding funnel of the eight CC founders so that every recombination site in the CC population is uniquely generated
| THE USAG E OF THE CC MOUS E P OPUL ATION
All the conducted projects in our laboratory were based on the idea of using mice of different CC lines as the genetic reference population, and determine their response toward an environmental challenge that affect the phenotype of interest. Depending on the nature of the environmental challenge and pathogenesis of each disease, the experiment period varies between few days to months, while phenotypic data are recorded at different time points starting at the initial time point of the experiment (time zero) up to the terminal time point. Subsequently, data analysis is performed using the IBM SPSS software platform for one-way and two-way analysis of variance (ANOVA) tests, which determines the significance level of the observed phenotypic variance between the CC lines and their cross-interactions. Next, linkage analysis between phenotypic and genotypic data is performed using the HAPPY software for mapping the QTL and reveal the candidate genes related to the measured phenotype (trait). Figure 2 summarizes the overall frame and steps for implementing an experiment using the CC mouse models.
Based on our experience and obtained and published results
from the different projects, we found that assessing a minimum of 30 CC lines in each experiment may provide a sufficient statistical power for the QTL mapping and data analysis. The mice study cohort should include the representation of both sexes from each CC line, with the number of animals range from 3 to 5 from each sex (ie, 6-10 mice in total from each CC line). It is noteworthy that the limiting factor of the cohort selection is the breeding rate of each individual CC line, which varies between the CC lines due to their genetic background structure. Therefore, cohort selection during the experiment period was performed in batches and not at once, where at the end of each breeding cycle (3 weeks period) a batch (group) of mice from different available CC lines is selected. In general, completing the assessment of entire experimental cohort for covering both sexes of 30 and more CC lines probably requires at least 10-12 breeding cycles (batches). Mapping QTL and identifying the founders at each interval were calculated using the HAPPY HMM. 26 Basic required equipment for conducting a given phenotype assessment include the following:
1. Appropriate small animal unit (SAU) for mouse housing.
2. Rooms and SAU held at 22°C and 12 hours of light/dark cycle. 
| Protocol steps
1. Turn on the DEXA scanner and then the computer.
2. Login to the Piximus software ("Lunar PIXImus").
3. Start system calibration ("Calibration Main") using the DEXA phantom and following the machine manual instructions. Only if the quality control passes, move to next step. If not, then follow the manual instructions for trouble shooting.
4. Create a folder to store your project scans.
5. Animal preparation for the scan: The mouse should be motionless during the DEXA scan by using anesthetics or sacrifice the animal prior the scan if it is terminal point of the experiment.
6. Animal scan: Place the mouse on the on the dedicated plastic tray of the scanner. Press "F3" (measure subject) then fill in the animal F I G U R E 2 General steps by sequential order for implementing an experiment using the CC mouse model. Initial step is the selection of the CC lines mice cohort and design the environmental challenge, then start the experiment period and data collection until terminal time point, and final step focusing on statistical data analysis, QTL mapping, gene expression, and eventually translation from mouse to human details (ID/Code), which be used as the scan name. Click "OK" to start the scanning. Watch the system signs for radiation (green/yellow icon) during the scanning process and keep away until the icons disappear and the mouse image appears on the computer screen.
7. Save file for the completed scan.
8. Image processing: It is possible to define a region of interest (ROI) labeled in a green square while in a red circle is the excluded region of the image.
9. To shut down the machine: Press "ESC" and exit the animal scan, then turn off the DEXA scanner and computer.
Additionally to the DEXA scan, manually measurements were performed for each mouse in order to define further body size phenotypes for determining the variation between the different CC lines. 
| Basic

| Protocol steps
1. Peripheral blood (~100 µL) was collected from the orbital venous plexus of each immune-competent mouse using heparin-washed glass Pasteur pipettes.
2. Mice were anesthetized using ketamine and xylazine (120 and 8 mg/kg body weight, respectively) before blood sampling. 4. Red blood cells were subjected twice to lysis procedure for 30 minutes at 4°C using 400 µL of lysing buffer (Quality Biological Inc Gaithersburg, MD). After full lysis, the labeled mixture was washed with phosphate-buffered saline (PBS; 1200 rpm 7 minutes) and suspended with 300 µL 0.5% paraformaldehyde PBS buffer.
Flow cytometry:
The cells were kept at 4°C until use. Samples were run on FACS scan. At least 10 000 and up to 50 000 events were acquired per sample.
| Basic protocol 3
| Type 2 diabetes and metabolic syndrome assessment
This protocol focus on the assessment of the glucose tolerance ability of the mouse as an indicator for the development of impaired glucose tolerance (type 2 diabetes) in response to different diets, standard rodents diet vs high-fat diet (HFD; 42% fat). 9. At the end of glucose reads after 180 minutes, the IPGTT is completed and mice should be returned to their home cages for recovery with free access to food and water. Next day, check on the mice to make sure that they are vital and recovered well.
| Basic protocol 4 2.4.1 | CC lines for studying of colorectal cancer
One form of the inherited colorectal cancer is familial adenomatous polyposis (FAP) syndrome, a rare dominant genetic disease, which is characterized by multiple intestinal polyps. [27] [28] [29] [30] [31] It is caused by a functional mutation in the adenomatous polyposis coli (Apc) gene.
In order to investigate the syndrome in vivo, Apc Min+/− mouse was developed, imitating the polyp phenomenon in humans. [32] [33] [34] [35] [36] In previous studies, Min +/− mouse was used for identifying the genes 
Genotypes of the F1 for C57BL/6Apc
Min+/− was determined by PCR.
F1 (CC-C57BL/6Apc
Min+/− ) were kept for 5 months on a standard mouse chow diet and water ad libitum. 
5. The small intestine were divided into three segments (SB1-proximal, SB2-middle, and SB3-distal), and the colon was kept as whole and spread over a 3-mm paper.
6. The intestines were fixed in 10% NBF overnight and stained with 0.02% methylene blue. The samples were then examined by binuclear.
7. The number and sizes of polyps in each of the four intestinal subregions were recorded as described. 11.6 Mb. Use of variation data from the genomes of the CC founder strains refine these QTLs further and suggest several candidate genes. 17 To our knowledge, this was the first report mapping susceptibility loci for invasive aspergillosis in immune-competent mice.
| Protocol steps
1. Immune-competent mice of both sexes were challenged with 10 7 spores by intravenous (IV) in the tail.
2. Mice were on a standard mouse chow diet and water ad libitum.
3. Surviving mice were censored at 28 days.
4. The response was measured as survival time (days). 
| Basic
| Protocol steps
1. Immune-competent mice of both sexes were subjected to IP challenge with 10 4 CFU of Kp-2 serotype.
3. Surviving mice censored at 15 days. The disease is initiated by periodontal pathogenic bacteria, which accumulate as subgingival biofilm and stimulate an inflammatory response in the host gingiva. 41 An excessive or sustained response leads to chronic inflammation, which is a potent amplification system for recruiting humoral and cellular components of the immune system. Recently, several lines of evidence suggest that there is a significant genetic component associated with the susceptibility to chronic periodontitis. 42, 43 We use the oral mixed infection system (of the two anaerobic gram negative bacteria P gingivalis and F nucleatum) as was previously described. 44 The phenotype is measured as the residual alveolar bone volume (in mm 3 ) after infection using the micro-CT scan, which provides an accurate measurement of the attachment loss around the animal teeth. 45 
The response was measured as survival time (days).
F I G U R E 7 Mean survival time (days) of different CC lines in response to
| Protocol steps
1. Immune-competent mice of both sexes were selected for the experiment.
3. P gingivalis 381 and F nucleatum strain PK 1594 were grown in peptone yeast extract containing hemin and Vitamin K (Wilkins Chalgren broth, Oxoid Ltd, UK), in an anaerobic chamber with 85% N 2 , 5% H 2 , and 10% CO 2 followed by three washes in PBS.
4. Bacterial concentrations were measured spectrophotometrically standardized to OD 650 nm = 0.1 for P gingivalis, corresponding to 10 10 bacteria/mL, and OD 660 nm = 0.26 for F nucleatum, corresponding to 10 9 bacteria/mL.
5. The mice were treated with sulfamethoxazole (0.8 mg/mL) in drinking water for a continuous period of 10 days, followed by an antibiotic-free period of 3 days, before oral application of mixed culture of P gingivalis and F nucleatum (400 μL of 10 9 bacteria/mL for each mice) at days 0, 2, and 4 (control groups were treated with PBS and 2% carboxymethycellulose instead).
6. At 42 days post infection, the mice were sacrificed after complete anesthesia, using two anesthetic materials (xylisine and ketamine) and maxillary jaws were harvested for micro-CT analysis.
A compact fan-beam-type CT system (MicroCT40, Scanco
Medical, Bassersdorf, Switzerland) was used for quantitative three-dimensional analysis as described previously.
8. Because the micro-CT measurement is a destructive procedure, control bone volume (CBV) and residual bone volume (RBV) due to infection cannot be measured in the same mouse. Consequently, it was not possible to obtain estimates of bone loss due to infection for individual animals.
9. Since the CC mice are inbred lines, genetic differences would not present among the mice in a given line, as discussed previously.
Therefore, the percentage of alveolar bone loss (PBL) for each infected mouse was calculated relatively to a control group from the same line.
| Basic protocol 8
| Host susceptibility to
Pseudomonas aeruginosa
The World Health Organization (WHO) listed P aeruginosa as one of the leading resistant pathogens with greatest public health concern, and is one of the major bacterial infections (10%-15% of cases) in hospitals and health care systems worldwide. Severe infection with P aeruginosa is typical among intensive care unit (ICU) patients with high risk for development of ventilator-associated pneumonia (VAP) and sepsis. 46 Wide variations are observed in the host response toward P aeruginosa infection, mainly in individuals at risk and patients with cystic fibrosis. So far, many studies investigated on dissecting the P aeruginosa genotypic features that might be underlying the variations in the host response leading to differential disease phenomenon and pathogenesis. [47] [48] [49] [50] [51] Yet, recent studies focused on dissection the host genetic background that might be playing crucial role controlling the variations in response severity. 52 To address this approach, various studies in murine models assessed multiple F I G U R E 9 Collaborative Cross (CC) lines alveolar bone volume changes in response to oral mixed infection. A dark gray column presents control bone volume (CBV) and a light gray column presents residual bone volume (RBV). Labeled with asterisk (*) are 6 CC lines of total 23 CC lines (eg, Il26, IL57, IL72, IL182, IL196, and IL711) showing a significant bone loss (P < 0.05) and considered to be susceptible to the infection. The x-axis represents the CC lines while the y-axis represents the alveolar bone volume (mm 3 ).
mice strains infected by P aeruginosa and repeatedly the results confirmed significant variation in infection response between the inbred strains. 48, 53 As step forwards fine mapping of these regions in the genome using the CC mouse population, Lore' et al 54 assessed a total of 92 mice (50 males and 42 females) generated from 17 CC lines and challenged by P aeruginosa infection (intratracheal injection), the host response was determined for 7 days in terms of survival time (days) and body weight (grams) changes. As reported, the CC lines varied significantly in their survival time ( Figure 10A ) ranging between lethal response (survival 1.5 days) and complete resistance (100% survival). 54 As well, the CC lines varied in their body weight changes following the challenge, where few CC lines showed significant decrease in body weight and others showed recovery of BW after day 5. Figure 10B summarizes the mean survival time (MST) and percentage change in body weight at day 1 (CBW1). Hereby, using few lines of the CC population, we demonstrate the role of strong genetic components controlling the host response despite fixed and strictly controlled environmental conditions. 54
| Protocol steps
3. Prior to the animal experiments, P aeruginosa AA2 clinical strain was grown in trypticase soy broth (TSB) to reach the exponential phase at 37°C.
4. The mice were anesthetized and infected by intratracheal injection with a 10 6 CFU implanted into the lung via the cannula, with all lobes inoculated as described.
5. The survival time and body weight of mice were monitored daily for 1 week; then, the surviving mice were euthanized and tested for CFU in the blood, liver, and lung. Figure 11C ). Similar variations were observed in body weight changes after the challenge ( Figure 11D ).
| Basic
| Protocol steps
2. Mice were on a standard mouse chow diet and water ad libitum. 4. The volume of the injection was set at 100 μL using 1-mL 25 G Syringes.
LPS from Escherichia coli (E coli 0111:B4) was ordered from Sigma
Aldrich.
6. The host response was monitored for 72 hours in terms of survival time (hours), body temperature and weight (grams) changes.
| COMMENTARY
The laboratory mouse is one of the most important tools in that the scientific community possesses to further understand mammalian gene function. The scientific community has taken advantage of this because of its fundamental similarity to humans (>95% at the gene level), physiological and anatomical similarity, relatively low cost compared to other mammals, and nearly 100 years of genetic study.
In genetically defined strains of mice, chromosomal regions responsible for the genetic variance of complex traits can be mapped as QTL in experimental populations available for precise study under defined conditions. 1, 23, 51 Once QTL is identified, genetic analysis can be extended successfully to humans. 4, 5 It has been suggested that the variation among strains of mice can be used for mapping QTL associated with susceptibility to chronic and infectious diseases. [6] [7] [8] [9] [10] Here, we propose to use advanced next-generation approach for determining the genes involved in the development of complex trait diseases and various comorbidities using the CC mouse GRP. Once inbred lines of mice are crossed, the cross-prog- publications. 8, [12] [13] [14] [15] [18] [19] [20] [21] [22] [23] [24] 59 The CC mouse model is the focal point in our research, having exclusive access to the CC lines produced at our laboratory at Tel-Aviv University (TAU). The CC lines were three times genotyped, once using 620 000 SNPs markers of mouse diversity array, 25 Next, linkage analysis between phenotypic to genotypic data is performed using the HAPPY software for mapping the QTL and reveal the candidate genes related to the measured phenotype (trait). 
CO N FLI C T O F I NTE R E S T
None.
O RCI D
Fuad A. Iraqi https://orcid.org/0000-0001-5525-206X
R E FE R E N C E S
